Devices & Diagnostics A few golden rules when it comes to mergers and acquisitions By Arundhati Parmar
Daily The mergers-and-acquisitions market is doing quite well and a potential cure for superbug MRSA is found in a 1,000-year-old text (Morning Read) By Nicole Oran
Providers Healthcare Docket: Feds and States Move to Curb Private Equity’s Takeover of Healthcare By Ron Harman King
Daily, MedCity Influencers How Marketing Fueled the Opioid Overdose Crisis and What We Can Learn From It By Suzette Glasner-Edwards
Consumer / Employer, Health Tech Deloitte: 7 Trends Shaping Healthcare and Life Sciences in 2024 By Marissa Plescia
Sponsored Post PE Investments, Acquisitions Fuel New Stages of Growth for Healthcare and Life Science Companies By Stephanie Baum
Health Tech, Legal UPMC’s Monopoly Keeps Wages Low and Prevents Workers from Unionizing, Lawmakers Say By Katie Adams
Daily, MedCity Influencers, BioPharma, Artificial Intelligence, Health Tech Planning ahead while looking back: What the pandemic collectively taught us By Niven R. Narain
MedCity Influencers, Legal Why the FTC’s recent decision to not study PBMs might hurt consumers and independent pharmacies By David McKay
Health Tech Survey finds execs aware and concerned about rampant patient data inaccuracies By Emma Bardin
Legal, Policy, Physicians Saving private practice? Navigating the legal and ethical minefield of physician-private equity deals By Khadijah M. Silver
